Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study
about
Cooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinomaWeekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma.Phase I Dose-Escalation Study of Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients With Advanced Esophageal CarcinomaElemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility studyPhase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinomaPhase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients.The significance of lymph node status as a prognostic factor for esophageal cancer.Influence of preoperative docetaxel, cisplatin, and 5-fluorouracil on the incidence of complications after esophagectomy for resectable advanced esophageal cancer.Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study.Case involving long-term survival after esophageal cancer with liver and lung metastases treated by multidisciplinary therapy: report of a case.
P2860
Q35074273-B33EE292-6F11-4341-ABBF-ECEB45483263Q35375610-B15F635D-A93E-4EF2-ABEB-DDD50C6A925BQ36104323-23453B74-C834-4539-9AF5-808CF7413370Q36400298-92C0856F-1856-4B88-AF4C-60760A6C4EE4Q36940910-EB473E6D-43AD-4D88-9230-23C668E5F1CCQ37142445-D3468E12-8F71-4D33-8C39-E96CA4F8A814Q37902946-E5BEDF69-EDA3-4A45-BFE3-00005C97FED5Q37923363-A52AE527-813B-4402-97FB-267500FF4EF7Q45340268-EC507BDB-5BC1-4A98-B077-13C743917F85Q48491599-E8877345-495E-4E97-8C3C-E5A6C5B6E6A7Q53159547-CE764E73-372A-41D4-808E-A02476BA23F9
P2860
Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@ast
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@en
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@nl
type
label
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@ast
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@en
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@nl
prefLabel
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@ast
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@en
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@nl
P2093
P2860
P1476
Biweekly docetaxel, cisplatin, ...... phase I dose-escalation study
@en
P2093
Kazuhiro Yoshida
Kazuya Yamaguchi
Shinji Osada
Takao Takahashi
Yoshihiro Tanaka
Yuichi Sanada
P2860
P2888
P304
P356
10.1007/S00280-010-1447-1
P577
2010-09-28T00:00:00Z
P5875
P6179
1022617962